Abbreviations used: bp, base pair; dUTP, deoxyuridine triphosphate; EDTA, ethylenediamine tetraacetic acid; HIF-l, hypoxia-inducible fac tor-I; Ie, ischemic core; Ip, ischemic peripheral; MCAO, middle cere bral artery occlusion; mRNA, messenger ribonucleic acid; PCNA, proliferating cell nuclear antigen; PFA, paraformaldehyde; PMN, poly morphonuclear; SMC, smooth muscle cells; VEGF, vascular endothe lial growth factor.
Summary: Both vascular endothelial growth factor (VEGF) and integrin O:vf3 3 play roles in angiogenesis. In noncerebral vascular systems, VEGF can induce endothelial integrin O:v f33 expression. However, it is unknown whether VEGF, like inte grin O:V f33' appears in the initial response of microvessels to focal brain ischemia. Their coordinate expression in microves sels of the basal ganglia after middle cerebral artery occlusion (MCAO) in the nonhuman primate model was examined quan titatively. Cells incorporating deoxyuridine triphosphate (dUTP+) by the polymerase I reaction at I hour (n = 3), 2 hours (n = 3), and 7 days (n = 4) after MCAO defined the ischemic core,(Ic) and peripheral regions. Both VEGF and integrin O:v f33 were expressed by activated noncapillary (7.5-to 30.0-j-Lm diameter) microvesse1s in the Ic region at I and 2
The appearance of new blood vessels (angiogenesis) is a relatively late response of the brain to focal ischemia (Krupinski et aI., 1994; Chuaqui and Tapia, 1993) . The signals, their timing, and sequence of presentation for angiogenesis after the initial ischemic events have not been established (Okada et aI., 1996) . The appearance of leukocyte adhesion receptors on microvascular endothe lium (Okada et aI., 1994; Haring et aI., 1996) and changes in microvascular integrin expression (Wagner et aI., 1997) within the first hours after middle cerebral hours after MCAO. At 7 days after MCAO, the number of VEGF+, integrin O:v f33 +, or proliferating cell nuclear antigen positive microvessels had decreased within the Ic region. The expressions of VEGF, integrin O:v f33' and proliferating cell nuclear antigen were highly correlated on the same microves sels using hierarchical log-linear statistical models. Also, VEGF and subunit O: v messenger ribonucleic acids were coex pressed on selected microvessels. Here, noncapillary microves sels are activated specifically early during a focal cerebral isch emic insult and rapidly express VEGF and integrin O:V f33 to gether. Key Words: Cerebral ischemia-Microvessel Angiogenesis-Vascular endothelial growth factor-Integrin O:V f33' artery occlusion (MCAO) suggest that signals for micro vascular cell activation and angiogenesis may be gener ated early during ischemia.
Vascular endothelial growth factor (VEGF), also known as vascular permeability' factor, has been impli cated in endothelial cell proliferation, permeability, and angiogenesis (Dvorak et aI., 1995; Senger, 1996) . Ex pression of VEGF and its receptors, flt-l and KDR, has been observed in developing organs during embryogen esis and in several pathologic conditions, including isch emic injury of the brain (Kovacs et aI., 1996; Hayashi et aI., 1997) and the myocardium (Li et aI. 1996) , wound healing (Brown et aI., 1992) , and in several inflammatory conditions (Detmar et aI., 1994; Fava et aI., 1994) . In vitro studies show that VEGF stimulates the expression of integrin CXV133 in microvascular endothelial cells in addition to tissue factor, osteopontin, and plasminogen activator expression (Clauss et aI., 1996; Zucker et aI., 1998; Pepper et aI., 1991; Senger et aI., 1996) . In the rodent, VEGF antigen and messenger ribonucleic acid (mRNA) appear from 5 to 24 hours after MCAO, late after the onset of focal ischemia (Kovacs et aI., 1996; Hayashi et aI., 1997) .
Integrin cxvl33' a cellular receptor for several Arg-Gly-VASCULAR VEGF AND <X V f33 EXPRESSION IN ISCHEMIA /039
Asp (RGD)-containing ligands, plays a significant role in the processes of angiogenesis (Brooks et aI., 1994) . Among the variety of ligands recognized by integrin <XV f33 are fibrin(ogen), von Willebrand factor, vitronec tin, thrombospondin, osteopontin, and the extracellular matrix proteins laminin and collagen (Cheresh, 1993) . In the vasculature, integrin <xy f33 is expressed by endothe lial cells, smooth muscle cells (SMC), activated leuko cytes, and macrophages and has been shown to mediate tumor angiogenesis. Vascular endothelial cell migration involves the ligation of integrin <XV f33 with vitronectin, whereas SMC migration involves the interactions of in tegrin <xy f33 with osteopontin and vitronectin (Leavesley et aI., 1993) . It has been demonstrated that integrin <xy f33 promotes adhesion-dependent survival in angiogenic blood vessels (Brooks et aI., 1994) . Okada et ai. demon strated that integrin <xy f33 (but not integrin <Xy f3 s , the receptor for vitronectin) appears on noncapillary mi crovessels in the basal ganglia within 2 hours of MCAO (Okada et aI., 1996) . Its appearance was significantly associated with fibrin (one of its ligands) deposited within the microvessel lumina at all times after MCAO. Whether this significant association results from in creased microvascular permeability, endothelial cell or SMC reactivity, or from separate unrelated events is im portant for understanding the fate of cerebral microves sels and neurons after MCAO (Okada et aI., 1994; Okada et aI., 1996; Tagaya et aI., 1997) .
The hypothesis tested by this study is that microvas cular integrin <xy f33 expression is increased together with the appearance of VEGF and evidence of endothelial cell and SMC activation within the first moments after the onset of experimental focal brain ischemia. Furthermore, these changes are related to neuron injury. Here, to test the null hypothesis of no co-localization, the number of microvessels expressing proliferating cell nuclear anti gen (PCNA), VEGF, and integrin <xy f33 within the isch emic and nonischemic regions were tabulated for each subject after MCAO (at 1 hour, 2 hours, and 7 days). Log-linear models then were fitted to pairwise frequen cies in multi way tables to determine the significance of any relation among PCNA, VEGF, and <XV f33 expression within the subjects. This study is the first to demonstrate that microvascular expression of integrin <xy f33 is related to VEGF up-regUlation in reactive cerebral microvascu lature displaying PCNA in the early moments of focal cerebral ischemia. It also provides evidence of an or dered temporal and topographic connection between mi crovascular activation and neuron injury during early MCAO.
MATERIALS AND METHODS

Experimental focal cerebral ischemia
Brain tissues from 13 adolescent male baboons (Papio anubis!cynocephalus) were used for this study. All animals were neurologically normal before MCAO and apparently free of infections or inflammation during the experiments. All pro cedures in this study were approved by the Institutional Animal Research Committee and were performed in accordance with the standards published by the National Research Council (Guide for the Care and Use of Laboratory Animals) and the U.S. Department of Agriculture Animal Welfare Act. In com pliance with these standards, efforts were made to ensure that the subjects were free of pain or discomfort. The principal investigator, veterinarians, and primate handling staff were pre sent for all procedures.
In the following experiments, three cohorts of subjects un derwent MCAO for I hour (n = 3),2 hours (n = 3), or 7 days (n = 4), compared to a control group (n = 3), which under went no procedure. The 7-day cohort comprised subjects that underwent MCAO during surgical implantation and displayed persistent unilateral neurologic defects thereafter. Preparation of the awake baboon MCAO stroke model has been described in detail elsewhere (del Zoppo et aI., 1986; del Zoppo et aI., 1991) . In brief, under general anesthesia with isoflurane using a transorbital approach, an inflatable balloon catheter assembly was placed around the MCA proximal to the origin of the lenticulostriate arteries. The MCAO was achieved by inflating the balloon in the awake subject. All experiments were termi nated under thiopental sodium anesthesia by transcardiac per fusion with an isosmotic perfusion fluid containing heparin (2000 lUlL), sodium nitroprusside (6.7 fLmollL), and bovine serum albumin (25 gIL). Tissue blocks (1.0 x 1.0 x 0.5 cm) from symmetrically located sites of basal ganglia were excised. Alternate blocks either were embedded in Tissue-Tek OCT compound (Miles, Inc., Elkart, IN, U.S.A.), frozen in isopen tane/dry ice, and stored at -80GC until use or were fixed with 2% paraformaldehyde (PFA) for 24 hours and embedded in paraffin for the immunohistochemical and in situ hybridization studies.
Antibodies
Poly clonal antibodies against VEGF (Santa Cruz Biotech nology, Inc., Santa Cruz, CA, U.S.A.) and integrins containing subunit cty (integrin ctyf33 and ctyf3s) (Chemicon International, Inc., Temecula, CA, U.S.A.), and monoclonal antibodies against PCNA (PC-lO) (Sigma BioSciences, St. Louis, MO, U.S.A.) and integrin ctyf33 (LM609) (Chemicon International, Inc.), were used in this study. The anti-VEGF polyclonal anti body was made against the NH3-terminal peptide (1 to 20 resi dues) of VEGF. The specificity of VEGF immunoreactivity was confirmed by disappearance of immunoperoxidase signals on blocking with the VEGF NH3-terminal peptide (Santa Cruz Biotechnology, Inc.) (data not shown). The anti subunit cty polyclonal antibody cross-reacted with integrin ctyf3s and ctyf33' Although the cross-reactivity of this antibody with ctyf3s might have led to overestimation of ctyf33 expression, a previ ous study with the same primate model demonstrated that ctyf3s was not expressed on micro vessels in the basal ganglia during ischemia (see Results) (Okada et aI., 1996) . This antibody also cross-reacts with platelet integrin ctyf33 in addition to micro vascular ctyf33; however, early after MCAO, the platelet con tribution was expected to be low based on previous data (Okada et aI., 1994) . Working dilutions of each antibody preparation were optimized in preliminary studies.
Immunohistochemistry
Immunoperoxidase studies were performed on either serial lO-fLm frozen sections or serial 3-fLm paraffin sections. Frozen sections were fixed with a 1:1 (volume/volume lv/v]) mixture of acetone and methanol for 5 minutes and treated with J 0 fLmo11L glycine in phosphate-buffered saline (100 mmollL 1040 T. ABUMIYA ET AL.
Na2HP04/NaHzP04 and 150 mmo11L NaCl adjusted to pH 7.4), then incubated with Blotto to block nonspecific antibody reactions (Johnson et al., 1984) . The fixed sections then were incubated with the primary antibody at 37"C for 2 hours, fol lowed by incubation with biotinylated horse (or goat) second ary antibodies to anti-mouse (or rabbit) IgG (Vector Laborato ries, Burlingame, CA, U.S.A.) at 37°C for 30 minutes. Avidin biotin complexes were generated with streptavidin-horseradish peroxidase (Vector Laboratories) and detected with 3-amino-9-ethy1 carbazole (AEC kit, Biomeda Corp., Foster City, CA, U.S.A.). The sections were then counterstained with Mayer's hematoxylin (Biomeda Corp.) or were left unstained. Paraffin sections were subjected to the same procedures after deparaf finization. For immunoperoxidase studies with the anti subunit (Xv polyclonal antibody using paraffin sections, the sections were incubated initially with 1.2 mg/mL trypsin (Sigma Bio Sciences) at 37"C for 15 minutes to unmask the epitope before the blocking treatment. Routine controls for each experiment included deletion of the primary and secondary antibodies and the use of an irrelevant primary antibody.
DNA scission
Cells displaying DNA fragmentation were detected by in corporation of digoxigenin-deoxyuridine triphosphate (dUTP) with DNA polymerase I as previously described (Tagaya et al., 1997) . After fixation with acetone and methanol, frozen sec tions were incubated with 0.1 U/j-LL DNA polymerase I (Pro mega, Madison, WI, U.S.A.) and digoxigenin DNA labeling mixture (Boehringer Mannheim Corp., Indianapolis, IN, U.S.A.) in translation buffer (50 mmollL Tris-HCl [pH 7.5], 10 mmollL MgS04, and 50 j-Lg/mL bovine serum albumin) at 37°C for 2 hours. The sections were subsequently incubated with horseradish peroxidase-conjugated anti-digoxigenin anti body (Boehringer Mannheim Corp.) for I hour. The peroxidase signal was developed with 3-amino-9-ethyl carbazole (AEC kit, Biomeda Corp.). Paraffin sections were subjected to the same procedures after deparaffinization and pretreatment with 2 j-Lg/ mL proteinase K for 5 minutes. In each section, regions defined by cells incorporating dUTP (dUTP+) and regions peripheral thereto (dUTP-) were defined and designated ischemic core (Ic) and peripheral (Ip), respectively. Nonischemic regions were taken from stereotaxically identical sites in the contralat eral basal ganglia.
In situ hybridization
In situ hybridization was performed as described previously using 3 5 S_UTP cyclic RNA probes on paraffin sections only mollL HCl for 10 minutes and digested with 5 j-Lg/mL protein ase K for 10 minutes. After incubation in prehybridization buffer (50% formamide [v/v] , 0.3 mollL NaC!, 20 mmol/L Tris-HCl [pH 8.0], 5 mmollL ethylenediamine tetraacetic acid [EOTA], 1 % Oenhardt's solution, 10% dextran sulfate (weight! volume), and 10 mmollL dithiothreitol] at 42°C for 3 hours, the sections were hybridized with 1 x 10 6 cpm of 3 5 S-labeled ribo probe at 55°C for 18 hours. After hybridization, the sections were washed twice in 2 x sodium chloride/sodium citrate (SSC)/2 mmollL EOTA, treated with RNase A (5 to 20j-Lg/mL) for 30 minutes, and washed twice again in 2 x SSC/2 mmollL EDT A. A high-stringency wash of 0.1 x SCC/[3-mercaptoethanollEOTA was performed at 55°C for 2 hours followed by washing four times in 0.5 x SSC. The sections were coated with NTB2 emulsion (Kodak, New Haven, CT, U.S.A.) and exposed in a sealed box at 4°C for 4 to 6 weeks. After development, the sections were counterstained with Ri chardson solution.
Quantitative analysis
The absolute number and size (the minimum transverse di ameter) of microvessels that demonstrated signals by immuno histochemical study or by in situ hybridization were quantified with the aid of computerized video imaging microscopy (del Zoppo et al., 1991) . A matrix of 100 nonoverlapping micro scopic fields at 400x magnification comprised each 6.0-mm 2 region of interest. Two identical regions of interest were chosen within the Ie and Ip region, and one region of interest was chosen within the nonischemic region and in the left basal ganglia of control subjects. These regions of interest were su perimposed in consecutive sections (immunostaining or in situ hybridization) and used to assess coexpression of the epitopes of interest on single microvessels or in groups of microvessels.
Statistical analysis
All values are expressed as the mean ± SO. Within each animal, microvessels were cross-classified according to the presence or absence of PCNA, VEGF, and integrin (X V [33 an tigen or transcript using appropriate probes at 1 hour, 2 hours, or 7 days after MCAO. The corresponding counts were tabu lated in multi way frequency tables. Hierarchical log-linear models, a standard statistical technique for categorical data analysis (Bishop et al., 1975) , were used to analyze relations among these factors, and, in particular, to assess the null hy pothesis that PCNA, VEGF, and (Xv[33 expression were inde pendent of one another. The quality of the fit of the log-linear models was assessed with deviance and chi-square statistics, with larger (nonsignificant) P values connoting adequate fits. Calculations were performed in Systat 6.0 for Windows (Wilkinson, 1996) . Otherwise, significance was set at 2P < 0.05.
RESULTS
Patterns of nuclear DNA scission after middle cerebral artery occlusion
Cellular dUTP incorporation defined the regions of ischemic injury in the ipsilateral basal ganglia of all MCAO animals. Neurons, astrocytes, and microvascular cells labeled by digoxigenin-dUTP appeared in topo graphic patterns similar to those previously reported (Tagaya et aI., 1997) . At 1 and 2 hours after MCAO, dUTP was incorporated into nonvascular cells in clusters but into few microvascular cells within the Ie region. From a total of 66. 1 ± 25.8 dUTP+ cells/mm 2 in the Ic region at 2 hours after MCAO, only 0.8 ± 0.2 dUTP+ cells/mm 2 were associated with microvascular structures. By 7 days after MCAO, the number of dUTP+ micro vascular cells had increased to 5.2 ± 2.4 dUTP+ cells/ mm 2 . At any time point, dUTP incorporation was asso ciated predominantly with capillaries and small noncap illary microvessels with a mean diameter of 8.4 ± 3. 9 /-Lm ( Fig. 1 ).
PCNA expression in microvessels after middle cerebral artery occlnsion
Among all experiments, no detectable evidence of PCNA, integrin <Xv I33' or VEGF was seen in any non-
ischemic basal ganglia. However, PCNA was found within the ischemic basal ganglia at both 1 or 2 hours after MCAO, predominantly in the Ic region. The PCNA + nonvascular cells were clustered predominantly within the border zone of the Ic region, whereas in non capillary microvessels PCNA was observed in the endo thelium and the medial SMC, where it co-localized equally with VEGF or integrin <X V 133 in the Ic region ( Fig. 1, Table 1 ). The number of microvessels displaying PCNA increased from I to 2 hours after MCAO (2.1 ± 1.9 to 6.0 ± 2.4 vessels/mm 2 , 2P = 0.144), but this difference did not reach significance ( .,
., a; 10 ., .,
., II) \I) > ., ., \I) > PCNA immunoreactivity at 2 hours after MCAO. By 7 days after MCAO, the number of PCNA immunoreactive microvessels in both the Ie and Ip regions was low (0.4 ± 0.4 and 0.7 ± 0.4 vessels/mm 2 , respectively).
Integrin txV 133 expression in micro vessels after middle cerebral artery occlusion Because LM609 consistently cross-reacts with inte grin (X V �3 only in frozen tissue, a polyclonal antibody against (Xv' which cross-reacts with (XY�3 (and (XY�5)' was used against the PFA-fixed tissue. A significant cross-correlation between the number of microvessels identified by both antibodies in frozen tissues (n = lO, r = 0.9421, 2P < 0.0001) and between LM609 (frozen) and the polyclonal antibody (PFA-fixed) (n = lO, r = 0.8940, 2P ::. 0.000l) was shown in preliminary experi ments. It was concluded that the polyclonal antibody could identify microvascular (XY�3 expression in PFA fixed tissue in a nearly equivalent manner to LM609 in the frozen preparations (see Materials and Methods) .
No microvessel-associated (Xv antigen was detected in nonischemic tissues. In the ischemic basal ganglia at 1 and 2 hours after MCAO, subunit (Xy antigen appeared in the media of 7.5-to 30.0-f,Lm diameter microvessels as previously shown (Okada et aI., 1996) (Fig. 1 ). In the Ie region, the number of (Xy-immunoreactive microvessels increased from 1 to 2 hours after MCAO (2.9 ± 1.7 vessels/mm 2 to 13.7 ± 5.8 vessels/mm 2 , 2P = 0.065) ( Table 2) . By comparison, a few microvessels expressing (Xy antigen also were found in the Ip region at 2 hours after MCAO. By 7 days after MCAO, the number of subunit (Xv-immunoreactive microvessels in the Ie region also had decreased but was not different from those in the surrounding Ip region (Table 2) .
VEGF expression in ischemic microvessels after middle cerebral artery occlusion
At 1 and 2 hours after MCAO, VEGF also appeared in the media of 7.5-to 30.0-f,Lm diameter microvessels in both the Ie and Ip regions (Fig. 1) . Within the Ie region, the area of VEGF+ microvessels was completely encom passed by the area of microvessels expressing integrin (X V �3 at all time points (Fig. 2) . Here, microvascular VEGF expression increased from 1 to 2 hours MCAO (1.5 ± 1.3 to 3.9 ± 1.0 microvessels/mm 2 , 2P = 0.105) ( Table 2) , but there were far fewer VEGF+ microvessels in the Ip region at 2 hours after MCAO (0.2 ± 0.3 mi crovessels/mm 2 ). By 7 days after MCAO, the number of VEGF-expressing microvessels in the Ie region had de creased to 0.4 ± 0.6 vessels/mm 2 .
The VEGF antigen also appeared in nonvascular cells at 1 and 2 hours after MCAO, including small clusters of astrocytes in the Ip region and in the Ic/lp border zone. Only within the Ie region, polymorphonuclear (PMN) leukocytes within or adjacent to microvessels or associ ated with hemorrhage were another nonvascular source of VEGF antigen (data not shown).
Co-localization of PCNA, VEGF, and integrin txy 133
Proliferating cell nuclear antigen, VEGF, and integrin (XY�3 were detected together on selected microvessels followed through multiple serial sections only within the ischemic basal ganglia (Fig. 3) . To determine the strength of the interaction of the three antigens, log linear models of the three pairs of antigens appearing on the same microvessels in the fixed samples were pre pared. With data from the Ic region, it was found that the log-linear models with subjects, and PCNA, VEGF, or (Xv (33 expression constituting first-order effects, together with second-order interactions (pairwise interactions be tween the first-order factors) fit the cell frequencies re markably well (Table 3 ). In this context, the significance of pairwise interactions connotes the lack of indepen dence of PCNA, VEGF, and integrin (Xv (33 expression. Furthermore, each of the three models (Table 3) was parsimonious in that deletion of any of the second-order interactions (or first-order effects) resulted in a signifi cantly poorer fit.
Despite substantial animal-to-animal heterogeneity of expression, subjects constituted a highly significant main effect in this log-linear modeling. The subjects could not be placed into relatively homogeneous subgroups by time (1 hour, 2 hours, or 7 days), as might have been anticipated at the beginning of the study, however. On the other hand, the subjects were found to cluster into three relatively homogeneous subgroups independent of time based on joint PCNA, VEGF, and integrin (Xv (33 expression in the Ie region (Fig. 4) . Notably, in the Ip region, there was no significant relation among the mi- No VEGF or subunit (Xv mRNA transcripts were de tected in the nonischemic regions of any subject. In the ischemic basal ganglia, VEGF and subunit (Xv mRNA were found on the same microvessels followed through multiple serial sections (Fig. 5) . Primarily in the Ie re gion, subunit (X v and VEGF transcripts were detected together in the media of noncapillary microvessels of 7.5-to 30.0-f.1m diameter, like (Xv (33 antigen (Okada et aI., 1996) (Fig. 6) . From 1 to 2 hours after MCAO, a modest increase in the number of microvessels display ing subunit (Xv and VEGF mRNA was seen only in the Ie region (Table 4) , which paralleled antigen expression. As with group I, which displayed significant co-localization of PCNA, VEGF, and integrin (Xv (33 antigens (Fig. 4) , the relation of (Xv subunit to VEGF transcripts in the vascular media of each subject also was significant (2P < 0.05).
The VEGF mRNA transcripts also were expressed by astrocytes and PMN leukocytes in the ischemic basal ganglia in a pattern similar to VEGF antigen. At I and 2 hours after MCAO only, astrocytes in the Ip region and the IclIp border zone showed VEGF mRNA transcripts. Interestingly, a relatively strong VEGF mRNA signal also was associated with cells next to some microvessels in the Ie region displaying VEGF antigen in the media. These VEGF-expressing cells had the morphologic fea tures of PMN leukocytes that had penetrated the vascular wall (Fig. 7) or histiocyte-appearing cells localized within the vascular wall (Kato et aI., 1996) .
DISCUSSION
The association of integrin uv133 with the microvas cular deposition of fibrin after MeAD. demonstrated by J Cereb Blood Flow Metab, Vol. 19, No.9, 1999 Okada et aI. (1996) highlights one rapid response of the cerebral microvasculature to ischemia. Whether and how the presentation of the ligand, fibrin(ogen) in this in stance, stimulates microvascular integrin u V 133 expres sion is not apparent. One explanation is that integrin uv 133 up-regulation is one event associated with micro vascular activation stimulated by ischemia, and that li gand presentation occurs by independent but parallel processes. Alternatively, integrin uv133 presentation may be stimulated by an activator that also increases endo thelial cell permeability, exposing the plasma to the tis sue factor surrounding the blood vessel (del Zoppo et aI., 1992). Senger et aI. (Senger, 1996) have shown that ex ogenous VEGF can induce integrin <Xv133 expression in microvascular endothelial cells in vitro. Also, VEGF is known to increase endothelial cell permeability. Further more, both integrin <Xv133 and VEGF up-regUlation have been shown to prevent endothelial cell apoptosis in vitro (Spyridopoulos et aI., 1997; Stromblad et aI., 1996) . Those observations suggest that a specific relation be tween VEGF and integrin <X V 133 could exist in the re sponses of microvessels to ischemia in the brain. If true, VEGF and integrin <Xv133 should coincide with evidence of microvascular activation in the initial response of the microvasculature to focal ischemia, and these responses could be time dependent. In this study, the corresponding null hypothesis of no co-localization of PCNA, VEGF, and integrin <Xv133 expression was effectively refuted by the log-linear modeling. Analysis of pairwise associa tions in individual microvessels demonstrated that a highly significant and coordinated expression of VEGF, integrin <xv I33' and PCNA was provoked in the microves sels of the Ic region beginning within 1 hour after MCAO.
The appearance of PCNA, a 29-kd accessory protein for DNA polymerases I) and E (Shivji et aI., 1995), in microvascular endothelium and SMC suggests a signifi cant immediate microvascular cell response to focal isch emia. Expression of PCNA in the nucleoplasm clearly reflects proliferative responses of cells to growth factors, DNA injury or repair, and other initiators of cell activa- tion during Gl and S phase (Kelman, 1997; Kurki et aI., 1988) . Expression of PCNA, then, is closely related to cell cycle initiation and could reflect an activated cell proliferative response after MCAO. There has been no report of microvascular or cellular presentation of this antigen in acute cerebral ischemia. Integral to chromo somal DNA replication (polymerase 8) and repair (poly merase E) (Shivji et al., 1995) , PCNA expression may be involved in the processes of DNA repair (Kelman, 1997) . As VEGF and integrin (XY�3 expression may be involved in suppression of the cell death pathway (Spyridopoulos et al., 1997; Strombladra et al., 1996) , their expression with PCNA may contribute to the preservation of cere bral vessels under ischemic conditions. In contrast to the absence of PCNA in microvascular endothelial cells and pericytes before 2 days in a rodent middle cerebral artery ligation model (Liu and Chen, 1994) , the current experi ments confirm that PCNA expression is one of the ear liest cerebral microvascular endothelial cell and SMC responses to ischemia. Vascular endothelial growth factor acts directly on en dothelial cells to stimulate their replication (Connolly et al., 1989) . Whereas VEGF did not increase proliferation of aortic SMC in culture (Weatherford et al., 1996) or in large-artery injury models (Asahara et aI., 1996) , exog enous VEGF has been shown to increase endothelial cell and SMC proliferation in 20 to 100 J-Lm collateral arte rioles of the ischemic lower limb in the rabbit (Takeshita et al., 1995; Tsurumi et al., 1996) . The cellular responses to VEGF in the skeletal muscle collaterals are consistent with the finding of VEGF in endothelial cells and SMC in PCNA + cerebral microvessels after MCAO.
J Cereb Blood Flow Metab, Vol. 19, No.9, 1999 Whereas the expressions of VEGF and integrin (XV�3 antigens on microvessels in the Ic region were signifi cantly related, the number and area of distribution of microvessels expressing integrin (XY�3 consistently ex ceeded those expressing VEGF antigen (Fig. 2, Table 2 ). This pattern may result from differences in antibody sen sitivity, contributions of VEGF from extravascular cel lular sources, or the effects of stimulation of integrin (XY�3 by non-VEGF agonists such as basic fibroblast growth factor. Fibroblast growth factor is reported to increase cell surface expression of the integrin (Xy and �3 subunits in cultured endothelial cells (Sepp et al., 1994) .
The consistently larger area of expression of integrin (XV�3 than VEGF also suggests that the two vascular elements may reflect differential responses to one or more products of ischemia. Induction of VEGF, and, perhaps, integrin (XV�3 on microvessels probably results from local hypoxia. Under hypoxic conditions, increased VEGF expression has been detected in cultured astro cytes (Ijichi et al., 1995) , tumor cell lines (Minchenko et al., 1994; Berse et al., 1992) , and arterial SMC (Brogi et al., 1994) . The VEGF and subunit (Xv genes both contain a hypoxia-inducible factor-l (HIF-l) response element in their promoter regions, which is activated by the binding of HIF-l under hypoxic conditions in vivo (Forsythe et al., 1996; Gleadle and Ratcliffe, 1997) . The presence of the HIF-l target sequence 5'-GACGTGGA-3' (bp 79 1 to 798 of (Xv integrin promoter cDNA, GenBank U07375) in both genes implies that induction of VEGF and perhaps subunit (Xv may be independently regulated by an HIF-l response. Further proof of the dependence of integrin MCA occlusion MCA occlusion Q'. v133 on VEGF expression requires detailed examination of HIF-l expression in this model with the use of specific inhibitors. We failed to find any time relation of joint microvas cular PCNA, VEGF, and integrin Q'. v133 expression in the Ie region. The known relation of VEGF expression to HIF-1 induction hints at a basis for the lack of temporal relation in these studies. It is likely that in the injured territory of e ach animal subject, subregions within Ic experience ischemic injury at various times based on the changes or shunting of blood flow during MCAO. The resulting topographic heterogeneity of expression means that the appearance of all three elements by 1 to 2 hours MCAO in a given subject would be "averaged" so that any time dependence of expression, if present, would be obscured.
Two previous studies of VEGF expression in experi mental focal cerebral ischemia in rodents differ from the VEGF, vascular endothelial growth factor. current results. Kovacs et ai. describe the appearance of VEGF on macrophages, neurons, glial cells, and endo thelial cells in the central ischemic region (from 18 hours to 5 days) and in the peripheral area (from 18 hours to 14 days) after irreversible MCAO in the rat (Kovacs et aI., 1996) . Separately, Hayashi et ai. describe up-regulation of VEGF antigen and mRNA by neurons and glial cells at 1 to 3 hours reperfusion after I-hour MCAO (Hayashi et aI., 1997) . The more rapid appearance of microvascu lar VEGF in the primate basal ganglia is consistent with the increased susceptibilities of neurons to is chemic injury (Tagaya et aI., 1997) . Other forms of in jury to the CNS may trigger VEGF. After cold injury and stab injury in rodent models, VEGF expression in astrocytes was maximal at 3 to 4 days (Papavassiliout et aI., 1997), whereas VEGF appeared at various times in PMN leukocytes (l hour to 1 day), astrocytes (3 to 8 days), macrophages (3 to 8 days), and vascular smooth muscle cells (6 hours to 10 days) (Nag et aI., 199 7) . The reasons for these temporal differences in VEGF appear ance in individual cell groups of nonprimate species are not known but may represent differences in species, model preparation, and injury type. In any event, the early coexpression of VEGF and integrin Q'. v133 in the primate represents a prompt response of noncapillary ce rebral microvessels to focal ischemia that may have a broad temporal presentation with persistent cerebral injury.
One possible effect of VEGF and integrin Q'. v133 ex pression is the stimulation of angiogenesis downstream. However, there is limited information about the late vas cular responses to focal cerebral ischemia. Tsutsumi et ai. demonstrated capillary bud formation by 7 days after MCAO in the infarct zone in a canine stroke model (Tsu tsumi, 1986; Tsutsumi et aI., 1986) . Chuaqui and Tapia subsequently demonstrated that in the infarcted zone, whereas most brain microvessels disappeared by 7 days after stroke onset, a subgroup of small normal-appearing muscular arterioles was frequently preserved within the first 4 weeks, followed by an increase in their number (Chuaqui and Tapia, 1993) . In stroke patients who sur vived from 5 to 92 days, the number of microvessels within the infarcted hemisphere was seen to increase (Krupinski et aI., 1994) . In the current study, there was no clear evidence that microvessel density increased in either the Ie or the Ip region of the ischemic basal gang lia by 7 days MCAO (data not shown). However, the presence of VEGF and integrin cxv f33 within Ie suggests that signals associated with vascular proliferation are generated early. The precise mechanism of VEGF and integrin cxv f33 up-regulation and of their relation to neo vascularization after focal cerebral ischemia are not known.
This report indicates that the early appearance of in tegrin cxv f33 and VEGF correlate with microvascular ac tivation and the activation of intravascular coagulation, leading to fibrin formation (Okada et aI., 1996) . Throm bin generation may provide a link between microvascu lar reactivity and permeability, and the local cleavage of fibrinogen (Aschner et aI., 19 97; Garcia et aI., 19 96) . It has been reported that osteopontin, a ligand for integrin cxv f3 3' is up-regulated late (more than 5 days) after MCAO in the cerebral parenchyma of the rat (Wang et aI., 199 8) . Ligation of osteopontin to integrin cxv f33 is enhanced when osteopontin is cleaved by thrombin (Sen ger et aI., 1996) . Although osteopontin may induce mi gration of both endothelial cells and SMC, no relation to the early microvascular responses to ischemia has been reported.
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The rapid appearance of PCNA, VEGF, and integrin CX V f33 on microvessels in the ischemic core also coincides with evidence of neuron injury in the nonhuman primate (Tagaya et aI., 199 7) . Possible relations that may deter mine whether the activation of the cerebral microvessels are linked to neuron injury have yet to be explored. How ever, a highly significant correlation between neuron in jury (or size of ischemic injury) and the appearance of pro-MMP-2 beginning within 1 hour after MCAO in this model has been shown (Heo et aI., 1999) . Zucker et ai. have shown that exogenous VEGF stimulates endothelial cells to generate MMP-2 (Zucker et aI., 1998). In the presence of coagulation factors, VEGF also may gener ate thrombin, known to activate pro-MMP-2 (Zucker et aI., 199 8). It has been proposed that the effects of MMP-2 on the microvascular basal lamina may be re lated to neuron injury (Heo et aI., 19 99) . With the asso ciation of TIMP-I and MMP-I expression to VEGF stimulation in both tumor and endothelial cell culture systems (Unemori et aI., 1992; Yoshiji et aI., 1998; Zucker et aI., 1998) . additional pathways to microvascu lar remodeling and thrombin generation may contribute to neuron injury.
To explore the downstream events from integrin cxv f33 expression, interventional approaches using peptides containing the RGD sequence, which effectively block integrin cxv f33 function in tumor angiogenesis, may be tried (Brooks et aI., 1994) . Similarly, functional inhibi tors of VEGF may prove useful to specifically define its relation to integrin cxv f33 expression and microvascular responses to ischemia. Ultimately, it is of interest wheth er the coexpression of VEGF and integrin cxV f33 on ac-tivated cerebral microvessels leads to changes in micro vascular integrity during ischemia, to microvascular re modeling and the generation of new vessels, and to alterations in neuron integrity.
